Care Rise

Mutual Advisors LLC Has $280,000 Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)


Mutual Advisors LLC lowered its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 10.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 3,624 shares of the company’s stock after selling 408 shares during the quarter. Mutual Advisors LLC’s holdings in GE HealthCare Technologies were worth $280,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in GEHC. First Command Advisory Services Inc. grew its position in GE HealthCare Technologies by 36,900.0% in the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock worth $25,000 after purchasing an additional 369 shares in the last quarter. Pin Oak Investment Advisors Inc. purchased a new stake in GE HealthCare Technologies in the 2nd quarter worth approximately $25,000. Householder Group Estate & Retirement Specialist LLC purchased a new stake in GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. Legacy Financial Group LLC bought a new position in shares of GE HealthCare Technologies in the 3rd quarter worth $26,000. Finally, OFI Invest Asset Management bought a new position in shares of GE HealthCare Technologies in the 3rd quarter worth $26,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

GEHC stock opened at $90.91 on Friday. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The company’s fifty day moving average price is $85.38 and its 200-day moving average price is $75.67. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The company has a market capitalization of $41.40 billion, a PE ratio of 30.10, a price-to-earnings-growth ratio of 3.14 and a beta of 0.97.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. During the same quarter in the previous year, the firm earned $1.31 earnings per share. The company’s quarterly revenue was up 5.3% compared to the same quarter last year. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.97%.

Analyst Ratings Changes

GEHC has been the topic of a number of recent analyst reports. Mizuho raised their price target on shares of GE HealthCare Technologies from $94.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday, February 7th. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their target price for the stock from $66.00 to $88.00 in a report on Monday, February 12th. HSBC initiated coverage on shares of GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a “buy” rating and a $100.00 price target for the company. Finally, Morgan Stanley boosted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $88.73.

Check Out Our Latest Stock Analysis on GEHC

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Featured Articles

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).



Receive News & Ratings for GE HealthCare Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for GE HealthCare Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.

link

Exit mobile version